Stock UniverseDerived research view · source repositories remain read-only

IDEXX Laboratories, Inc. (IDXX)

Life Science Tools / Diagnostics / MedTech · Healthcare / Diagnostics & Research
Score Band
High
Selection Score
44.19
Global Rank
125
Market Cap
52.29B
Latest Close
562.16
RS Composite
-17.64% · G#2521

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-2.95%
3M
-7.60%
6M
-22.56%
1Y
7.11%
3Y
20.95%
5Y
0.73%
10Y
541.95%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 455.25K · 30-day average: 659.36K · Max drawdown over stored range: -54.00%

Research Snapshot

Relative Strength vs SPX

RS Composite-17.64%
20D RS-2.39%
60D RS-15.36%
120D RS-27.54%
Global RS Rank2521 · 24.86% percentile
Qualified+ RS Rank964 · 23.37% percentile
Group ScopeQualified+
Primary RS Rank100 · 29.58% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank7 / 246
Primary Percentile97.56
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-05-054.45B2.76B1.41B1.10B13.591.87B220.79M1.65B81M62.05%31.63%24.63%42.10%37.13%200.53M299.85M

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$13.5941.4x$55.1810.2x$20.4927.4x$23.2324.2x

Shares Diluted: 81M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue3215.363367.3243660.9533897.5044303.702
Revenue Growth (YoY)18.795%4.726%8.72%6.461%10.422%
Gross Profit1889.4322004.3382189.972378.9272659.579
Operating Income932.028898.7651097.1281189.8371360.031
Free Cash Flow635.997394.146772.879808.0791057.129
Free Cash Flow Per Share7.3464.6599.2039.70713.047
EPS (Diluted) GAAP8.68.0310.0610.6713.08
EPS Growth28.167%-6.628%25.28%6.064%22.587%
EPS Non-GAAP
Gross Margin58.763%59.523%59.82%61.037%61.797%
Operating Margin28.987%26.691%29.968%30.528%31.601%
Profit Margin23.165%20.167%23.083%22.78%24.618%
Free Cash Flow Margin19.78%11.705%21.111%20.733%24.563%
Shares Outstanding (Diluted)86.57284.683.97883.24681.025
Shares Change (YoY)-0.173%-2.278%-0.735%-0.872%-2.668%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-051.14B63.35%362.59M31.78%278.45M24.41%3.4780.16M200.53M299.85Mprocessed
2025 Q42026-02-201.09B60.35%315.61M28.94%248.19M22.76%3.0880.48M180.07M374.84Mprocessed
2025 Q32025-11-031.11B61.83%354.85M32.11%274.61M24.85%3.4080.67M208.17M374.82Mprocessed
2025 Q22025-08-041.11B62.62%373.05M33.62%293.99M26.50%3.6380.99M164.59M449.81Mprocessed
2025 Q12025-05-01998.43M62.44%316.53M31.70%242.68M24.31%2.9681.92M163.97M449.80Mprocessed
2024 Q42025-02-21954.29M59.80%261.69M27.42%216.15M22.65%2.6282.55M288.27M449.79Mprocessed
2024 Q32024-10-31975.54M61.10%303.89M31.15%232.84M23.87%2.8083.06M308.64M524.76Mprocessed
2024 Q22024-08-061.00B61.70%263.80M26.29%203.30M20.26%2.4483.39M401.59M524.74Mprocessed
2024 Q12024-05-01964.10M61.52%298.96M31.01%235.58M24.44%2.8183.96M397.43M620.78Mprocessed
2023 Q42024-02-22901.60M58.36%245.30M27.21%194.52M21.58%2.3283.94M453.93M622.88Mprocessed
2023 Q32023-11-01915.53M59.85%275.28M30.07%212.23M23.18%2.5383.99M331.70M618.81Mprocessed
2023 Q22023-08-01943.63M60.71%296.14M31.38%224.24M23.76%2.6783.98M132.84M696.84Mprocessed
2023 Q12023-05-02900.20M60.32%280.40M31.15%214.05M23.78%2.5583.96M111.37M696.36Mprocessed
2022 Q42023-02-16828.57M58.53%226.53M27.34%172.21M20.78%2.0583.83M112.55M694.39Mprocessed
2022 Q32022-11-01841.66M60.19%244.83M29.09%180.94M21.50%2.1584.11M99.18M760.81Mprocessed
2022 Q22022-08-02860.55M59.73%179.07M20.81%131.98M15.34%1.5684.86M114.36M768.00Mprocessed
2022 Q12022-05-04836.55M59.62%248.34M29.69%193.97M23.19%2.2785.56M204.62M773.38Mprocessed
2021 Q42022-02-16801.09M56.97%199.19M24.86%162.77M20.32%1.8986.15M144.45M775.21Mprocessed
2021 Q32021-11-02810.42M58.35%225.96M27.88%175.24M21.62%2.0386.51M145.20M778.02Mprocessed
2021 Q22021-07-30826.14M59.23%259.25M31.38%202.58M24.52%2.3486.65M232.13M780.08Mprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.